.webp)
Announcements
We’re proud to announce our DMF (Drug Master File) approval
May 14, 2025
We’re proud to announce our DMF (Drug Master File) approval and successful commercial launch in the US market. This marks a significant step forward in our commitment to global healthcare excellence.
Approved DMF’s in US
Respiratory
Azelastine HCL
Budesonide
Ciclesonide
Fluticasone Furoate
Fluticasone Propionate
Formoterol Fumarate Dihydrate
Mometasone Furoate Anhydrous
Mometasone Furoate Monohydrate
Triamcinolone Acetonide
Anti-Inflammatory
Triamcinolone Hexacetonide
Under review DMF’s in US
Deflazacort
DMF’s Filed in US
Exemestane

